Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Clinical trial NCT00561392 · COMPLETED

Trial details

NCT number: NCT00561392
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2007-11-01
Primary completion: 2008-11-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.